EFFECTS OF EMPAGLIFLOZIN ON CARDIOVASCULAR MORTALITY BY PREVALENT OR INCIDENT HEART FAILURE IN THE EMPA-REG OUTCOME TRIAL
Fitchett, D., Zinman, B., Lachin, J.M., Mattheus, M., George, J., Johansen, O., Inzucchi, S.E.Volume:
32
Language:
english
Journal:
Canadian Journal of Cardiology
DOI:
10.1016/j.cjca.2016.07.124
Date:
October, 2016
File:
PDF, 369 KB
english, 2016